£51-60k
+ A generous stock option plan
5 days a week in office (Bermondsey)
Protein engineering platform
Job no longer available
Protein engineering platform
21-100 employees
Job no longer available
£51-60k
+ A generous stock option plan
5 days a week in office (Bermondsey)
21-100 employees
To accelerate the discovery of next-generation therapeutic antibodies.
Desirable
LabGenius is a protein engineering platform that integrates several technologies from the fields of machine learning, synthetic biology, and robotics. It uses computational methods to explore protein fitness landscapes and improve multiple drug properties simultaneously.
Historically, the discovery of protein therapeutics has been a labour-intensive, human-driven process, with scientists manually designing and executing experiments. This traditional approach is limited by our cognitive abilities to fully understand the complexity of biological systems. LabGenius is breaking these barriers with EVA, a smart robotic platform that not only designs and conducts experiments but also learns from them This continuous learning allows EVA to refine its understanding of genetic design rules, growing smarter with each experiment.
Currently, LabGenius is deploying EVA to develop novel antibody fragments for therapeutic areas, including solid tumours, where they offer significant advantages over traditional antibody formats. EVA's ability to engineer high-value drug properties - such as efficacy, potency, selectivity, and manufacturability - addresses challenges that have long hindered the field. This is an exciting development for the team, and they are now exploring how these principles can be applied more broadly to tackle human diseases.
Kirsty
Company Specialist at Welcome to the Jungle
Few candidates hear
back within 2 weeks
48% female employees
4% employee growth in 12 months
Apr 2024
$43.6m
SERIES B
Jan 2022
$1.3m
GRANT
Bermondsey, London, UK
James Field
(Founder & CEO)Earned a Bachelor of Science degree in Biology and Microbiology, a Master of Science degree in Systems and Synthetic Biology and a PhD in Synthetic Biology from Imperial.
Share this job